We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Denies Adapt’s Petition for Higher Standards for Naloxone Generics
FDA Denies Adapt’s Petition for Higher Standards for Naloxone Generics
The FDA rejected Adapt Pharma’s request to raise the standards for the approval of naloxone generics, arguing that products will be reviewed on a case by case basis.